How women make choices about surgery to prevent ovarian cancer
A study by researchers at Queen Mary University in London, UK, has investigated how women…
Browsing: BRCA1
New studies clarify which genes may raise breast cancer risk
Two large studies give a much sharper picture of which inherited mutations raise the risk…
Study evaluates cost-effectiveness of olaparib for metastatic pancreatic cancer
Studies have shown that utilising a PARP inhibitor in the management of patients with metastatic…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Researchers discover drug resistance mechanism in leukemia, ID treatment strategy
Like packaging designed to create a protective environment around a product, the mix of cells…
New recommendations on genetic testing for prostate cancer
A key area impacting prostate cancer risk and treatment is germline genetic testing, which involves…
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
Mayo researchers recommend all women with breast cancer diagnosis under age 66 be offered genetic testing
A study by researchers at Mayo Clinic, USA, published this week in the Journal of…
Both BRCA1-wild type and mutant triple-negative breast cancers show
Oncotarget features “MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S…
Study finds inflammation caused by radiation can drive triple-negative breast cancer
While radiation is successfully used to treat breast cancer by killing cancer cells, inflammation caused…